Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis.

Int J Mol Sci · 2021 · PMC8038067 · PMID 33800594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

It is interesting to note that when comparing genes after immunoprecipitations by the two antibodies (JARID2 and EZH2) in the two PF (endo or control PF) treated cells ( Table 1 B), the endo PF treated cells showed a trend of having a fold-change less than 1 when comparing JARID2 vs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.